• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pathogens .Non-SARS Non-MERS Human Coronaviruses: Clinical Characteristics and Outcome

tetano

Editor, Senior Moderator
Pathogens


. 2021 Nov 27;10(12):1549.
doi: 10.3390/pathogens10121549.
Non-SARS Non-MERS Human Coronaviruses: Clinical Characteristics and Outcome


Israa Saib[SUP] 1 2 [/SUP], Saud Aleisa[SUP] 1 [/SUP], Husam Ardah[SUP] 3 4 [/SUP], Ebrahim Mahmoud[SUP] 1 [/SUP], Ahmad O Alharbi[SUP] 1 [/SUP], Abdulrahman Alsaedy[SUP] 1 3 [/SUP], Sameera Aljohani[SUP] 2 3 5 [/SUP], Ahmed Alshehri[SUP] 5 [/SUP], Naif Khalaf Alharbi[SUP] 2 3 [/SUP], Mohammad Bosaeed[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

Human coronaviruses (HCoVs) have become evident sources of human respiratory infections with new emerging HCoVs as a significant cause of morbidity and mortality. The common four coronaviruses (229E, HKU1, NL63, and OC43) are known to cause respiratory illness in humans, but their clinical impact is poorly described in the literature. We analyzed the data of all patients who tested positive for at least one of the four HCoVs from October 2015 to January 2020 in a tertiary care center. HCoVs were detected in 1062 specimens, with an incidence rate of 1.01%, out of all documented respiratory illnesses. Detection of these viruses was reported sporadically throughout the years, with a peak of occurrence during winter seasons. OC43 had the highest incidence (53.7%), followed by NL63 (21.9%), HKU1 (12.6%), and 229E (11.8%). Most of these infections were community-acquired, with symptoms of both upper and lower respiratory tract. Co-detection with other viruses were observed, mostly with rhinovirus. 229E was the most frequent (26.4%) HCoV in patients requiring intensive care, while NL63 and 229E were the most common in patients requiring invasive ventilation. The highest 30-day mortality rate was observed in patients infected with 229E (6.4%). HCoVs are common circulating pathogens that have been present for decades, with 229E being the most virulent in this study cohort.

Keywords: Saudi Arabia; epidemiology; human coronaviruses; viral pneumonia.
 
Back
Top Bottom